All4NutraNo products in the cart.
All4NutraStartseite » News » FDA
Abstract This work presents a method optimization strategy for determining nitrite ions in pharmaceutical excipients. After derivatization, nitrite ions were...
Abstract Machine learning (ML) is expected to accelerate the developments of three-dimensional (3D) printed medicines. Despite ML’s potential, the need...
Abstract Halogens, particularly fluorine, chlorine, and bromine, play a pivotal role in modern drug discovery and development. Their incorporation into...
Abstract The Knowledge-Aided Assessment and Structured Application (KASA) is an initiative led by the FDA’s Center for Drug Evaluation and...
Abstract Orally disintegrating tablets (ODTs) are a solid oral dosage form designed to rapidly disintegrate in the mouth without the...
Abstract Parenteral therapies are vital in critical care, oncology, and nutrition, offering rapid onset, precise dosing, and high bioavailability. However,...
Abstract Excipients, historically regarded as inert, are now being recognised for their ability to actively modulate biological targets, including intestinal...
Abstract Excipients are essential components within drug products that contribute significantly to their overall quality, effectiveness, and safety. There is...
Abstract The enactment of Regulation No 1901/2006 on medicinal products for pediatric patients, Pediatric Research Equity and Best Pharmaceuticals for...
PRESS RELEASE Jakarta, 14 October 2025 — Chairperson of the Indonesian Food and Drug Authority (BPOM), Prof. Dr. Taruna Ikrar,...
Copyright: PharmaExcipients AG